Use of extended-release niacin in clinical practice

By Suryadevara Ramya S   Karas Richard H   Kuvin Jeffrey T  

Future Lipidology, Vol. 3, Iss. 1, 2008-02 ,pp. : 9-16

Future Medicine

Access to resources Recommend Favorite

A comparison of the pharmacokinetics of two different formulations of extended-release niacin

By Lauring B.   Rosko K.   Luo W.-L.   Wenning L.   Kissling J.   Roupe K.   Paolini J. F.   Wagner J.   Lai E.  

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 15-22

Informa Healthcare

Access to resources Recommend Favorite

Determinants of lipid goal achievement in patients on extended-release nicotinic acid/laropiprant in primary care clinical practice

By Dänschel Wilfried   Steinhagen-Thiessen Elisabeth   Buffleben Claudia   Pittrow David   Hildemann Steven K.  

Current Medical Research and Opinion, Vol. 29, Iss. 1, 2013-01 ,pp. : 33-40

Informa Healthcare

Access to resources Recommend Favorite

The effect of 24 months of combination statin and extended-release niacin on carotid intima–media thickness: ARBITER 3

By Taylor Allen J.   Lee Hyun J.   Sullenberger Lance E.  

Current Medical Research and Opinion, Vol. 22, Iss. 11, 2006-11 ,pp. : 2243-2250

Informa Healthcare

Access to resources Recommend Favorite

Flushing Profile of Extended-Release Niacin/Laropiprant at Initiation of Therapy in Asian Lipid Clinic Patients

By  

Cardiology, Vol. 114, Iss. 3, 2009-07 ,pp. : 192-198

Karger

Access to resources Recommend Favorite